Verona Pharma Stock Jumps 20%. It’s Being Bought for $10 Billion by Merck. - Barron's
1. Merck acquires Verona Pharma for approximately $10 billion. 2. Verona's Ohtuvayre FDA-approved for COPD treatment since June 2024. 3. Merck CEO states Ohtuvayre expands Merck's portfolio significantly. 4. Deal approval expected in Q4 from U.K. regulators. 5. Verona's shares surged 20% post-announcement, indicating strong market interest.